Cargando…

Health Outcomes of Population-Based Pharmacy Outreach to Increase Statin Use for Prevention of Cardiovascular Disease in Patients with Diabetes

BACKGROUND: In 2003, Group Health implemented a pharmacy-based, systemwide outreach effort to increase the preventive use of statins and angiotensin-converting enzyme inhibitors in enrollees at risk for cardiovascular disease, including all enrollees with diabetes. OBJECTIVE: To estimate the associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grembowski, David, Ralston, James D., Anderson, Melissa L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397924/ https://www.ncbi.nlm.nih.gov/pubmed/27459653 http://dx.doi.org/10.18553/jmcp.2016.22.8.909

Ejemplares similares

Vanderbilt Health Affiliated Network Statin Outreach Service
por: Terry, Christopher, et al.
Publicado: (2020)

Statin for the Primary Prevention of Cardiovascular Disease in Patients with Diabetes Mellitus
por: Koo, Bo Kyung
Publicado: (2014)

Statins for primary cardiovascular prevention in the elderly
por: Pedro-Botet, Juan, et al.
Publicado: (2015)

Prevalence of the Use of Aspirin and Statins for Preventing Cardiovascular Events in the Colombian Population with Type 2 Diabetes Mellitus: Comparison of 2008 and 2018
por: Machado-Duque, Manuel E., et al.
Publicado: (2021)

Community Engagement and Outreach Programs for Lead Prevention in Mississippi
por: Mitra, Amal K., et al.
Publicado: (2020)

Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease
por: Zhu, Lijun, et al.
Publicado: (2022)

Outreach
por: Gillies, James D
Publicado: (2006)

Correction: Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease
por: Zhu, Lijun, et al.
Publicado: (2022)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

The Impact of Statin Therapy on Cardiovascular Outcomes in Patients With Diabetes: A Systematic Review
por: Usman, Nia Uswanti Binti, et al.
Publicado: (2023)

A pragmatic cluster randomized trial evaluating the impact of a community pharmacy intervention on statin adherence: rationale and design of the Community Pharmacy Assisting in Total Cardiovascular Health (CPATCH) study
por: Evans, Charity D, et al.
Publicado: (2010)

Abolish Outreach!
por: Beacham, James
Publicado: (2018)

Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low‐Risk Population With Type 2 Diabetes Mellitus
por: Malmborg, Morten, et al.
Publicado: (2021)

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
por: Saadati, Hassan, et al.
Publicado: (2020)

Personalized Telephone Outreach Increased Health Insurance Take-Up For Hard-To-Reach Populations, But Challenges Remain
por: Myerson, Rebecca, et al.
Publicado: (2022)

Cardiovascular disease preventive effects of aspirin combined with different statins in the United States general population
por: Liu, Tao, et al.
Publicado: (2023)

Risk‐benefit analysis of use of statins for primary prevention of cardiovascular disease in subjects without diabetes
por: Chan, Juliana CN
Publicado: (2013)

Adherence to Statins in Primary Prevention: Yearly Adherence Changes and Outcomes
por: Slejko, Julia F., et al.
Publicado: (2014)

Statin drug-drug interactions in a Romanian community pharmacy
por: BADIU, RALUCA, et al.
Publicado: (2016)

Increased risk of diabetes with statin use: Reconsidering the use of high potency statins
por: Niazi, Asfandyar Khan
Publicado: (2014)

Hoping rosuvastatin for primary prevention of cardiovascular events, are all statins similar and are we ready for statinizing the globe?
por: Kumar, Arun H. S.
Publicado: (2016)

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
por: Byrne, Paula, et al.
Publicado: (2019)

Protocol for the CHORD project (community health outreach to reduce diabetes): a cluster-randomized community health worker trial to prevent diabetes
por: Islam, Nadia, et al.
Publicado: (2018)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
por: Kao, Yu-Cheng, et al.
Publicado: (2021)

Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives
por: Roszak, Sara E., et al.
Publicado: (2020)

Outreach
por: Barnett, Michael
Publicado: (2011)

Outreach
por: Sanchis-Lozano, M A
Publicado: (2006)

OUTREACH
por: D. Barney
Publicado: (2009)

Effectiveness of Statins as Primary Prevention in People With Different Cardiovascular Risk: A Population‐Based Cohort Study
por: Garcia‐Gil, Maria, et al.
Publicado: (2018)

Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009–2017
por: Thalmann, Inna, et al.
Publicado: (2023)

Wildfire smoke exposure and cardiovascular disease—should statins be recommended to prevent cardiovascular events?
por: Vuorio, Alpo, et al.
Publicado: (2023)

Primary prevention with statins in cardiovascular diseases: A Saudi Arabian perspective
por: Mahmood, D., et al.
Publicado: (2015)

Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease
por: Hope, Holly F., et al.
Publicado: (2019)

Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients
por: Strandberg, Timo E.
Publicado: (2019)

Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury
por: Coste, Joël, et al.
Publicado: (2019)

Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic
por: Malo, Sara, et al.
Publicado: (2022)

The Need for Outreach in Preventing Suicide among Young Veterans
por: Sareen, Jitender, et al.
Publicado: (2009)

Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study
por: Yang, Quanhe, et al.
Publicado: (2017)

Concept analysis of community health outreach
por: Shin, Hye Young, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v7q0dqpdd2jn19m8k9p4cb7qre